Skip to main content
NC State CVM
Think and Do The Extraordinary
GIVE to the College
Think and Do The Extraordinary
The Campaign for NC State CVM

SEARCH

By People

By Unit

By Research Area of Emphasis

By Student Focus Area

Profile

Alix Berglund, DVM, PhD

Research Scholar

Contact:

akberglu@ncsu.edu
Office: 919.513.7213

Biography

Dr. Berglund received her BS in Zoology in 2010 and her DVM in 2014 both from Washington State University. She then completed her PhD in Comparative Biomedical Sciences at NC State in 2018 under the mentorship of Dr. Lauren Schnabel. Her PhD work was funded by a Morris Animal Foundation Fellowship and her postdoctoral work by an American Association of Immunologists Careers in Immunology Fellowship. Her current research on the immunogenicity of allogeneic mesenchymal stem cells is funded by her NIH K01 grant. Additional research interests include regulation of MHC expression and development of the horse as a large animal translational model for immunology research.

Publications


View online at Google Citations
Affiliations
American Association of Immunologists
Comparative Medicine Institute
Certifications
American Association of Immunologists, Comparative Medicine Institute

Research Emphasis

Immunology, Regenerative Medicine
Dr. Berglund’s research interests are in the use of mesenchymal stem cells for the treatment of inflammatory and immune-mediated diseases. I am currently focused on reducing the immunogenicity of donor mesenchymal stem cells to develop more efficient and efficacious regenerative therapies. I am also interested in the regulation of MHC expression by TGF-β and how this mechanism protects tissues from damage by immune responses. Additional interests include developing the horse as a large animal translational model for immunology research.

News

Study: 'Stealthy' Stem Cells Better for Treating Tendon Injuries in Horses

The research could simplify the stem cell treatment process for ligament and tendon injuries in horses, and may also have implications for human stem cell therapies.